Shandong Sinobioway Biomedicine Co., Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 356.18 million compared to CNY 397.44 million a year ago. Revenue was CNY 357.08 million compared to CNY 402.71 million a year ago.

Net loss was CNY 14.69 million compared to net income of CNY 271 million a year ago. Basic loss per share from continuing operations was CNY 0.0223 compared to basic earnings per share from continuing operations of CNY 0.4108 a year ago. Diluted loss per share from continuing operations was CNY 0.0223 compared to diluted earnings per share from continuing operations of CNY 0.4108 a year ago.